Rice Hall James & Associates LLC Sells 1,381 Shares of ZimVie Inc. (NASDAQ:ZIMV)

Rice Hall James & Associates LLC lowered its stake in shares of ZimVie Inc. (NASDAQ:ZIMV) by 0.8% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 173,510 shares of the company’s stock after selling 1,381 shares during the quarter. Rice Hall James & Associates LLC’s holdings in ZimVie were worth $2,754,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Cetera Advisors LLC bought a new stake in ZimVie in the first quarter worth $2,615,000. Point72 Asset Management L.P. bought a new position in ZimVie during the second quarter valued at $3,993,000. Price T Rowe Associates Inc. MD increased its position in ZimVie by 6.3% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,531 shares of the company’s stock valued at $356,000 after acquiring an additional 1,275 shares during the last quarter. First Eagle Investment Management LLC boosted its stake in shares of ZimVie by 17.1% during the second quarter. First Eagle Investment Management LLC now owns 260,481 shares of the company’s stock valued at $4,754,000 after purchasing an additional 38,124 shares during the period. Finally, American Century Companies Inc. boosted its stake in shares of ZimVie by 212.8% during the second quarter. American Century Companies Inc. now owns 412,434 shares of the company’s stock valued at $7,527,000 after purchasing an additional 280,565 shares during the period. Institutional investors own 95.63% of the company’s stock.

Analyst Ratings Changes

Separately, Needham & Company LLC boosted their target price on shares of ZimVie from $20.00 to $23.00 and gave the company a “buy” rating in a research note on Friday, August 2nd.

ZimVie Stock Up 2.0 %

Shares of ZIMV opened at $14.04 on Friday. ZimVie Inc. has a 12-month low of $6.52 and a 12-month high of $22.40. The firm has a fifty day moving average price of $15.76 and a 200-day moving average price of $16.80. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.43.

ZimVie (NASDAQ:ZIMV) last announced its earnings results on Thursday, August 1st. The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.04). The firm had revenue of $116.81 million during the quarter. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. During the same period in the previous year, the company earned $0.17 EPS. On average, equities analysts expect that ZimVie Inc. will post 0.6 EPS for the current year.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.